Abstract

Motivation Atherosclerosis is the leading causes of death globally, but is challenging to study in vivo or in vitro due to the logistical and ethical challenges involved. A computational model has the potential to transform our ability to study the disease by being quick, simple and consistent to work with at no financial or ethical cost. However, no detailed, openly-available computational models exist. Clinical studies hint that pharmaceutical therapy may be possible. Here, we develop the first detailed, computational model of atherosclerosis to be built to systems biology standards and use it to develop multi-drug therapeutic hypotheses. Results We assembled high quality network maps and models describing atheroma development from the literature. Maps and mathematical models were produced using the Systems Biology Graphical Notation (SBGN) and Systems Biology Markup Language (SBML), respectively, and the model was constrained against laboratory and clinical data. We identified five drugs that potentially reverse advanced atheroma formation when acting in combination. Availability and Implementation The map is available from our publications in the Systems Biology Graphnical Notation Markup Language (SBGN-ML) file format. The model is available in the from the BioModels repository and from our publications, in SBML file format.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.